Effects of nateglinide and rosiglitazone on pancreatic alpha- and beta-cells, GLP-1 secretion and inflammatory markers in patients with type 2 diabetes: randomized crossover clinical study

BACKGROUND: To compare the effects of nateglinide and rosiglitazone on inflammatory markers, GLP-1 levels and metabolic profile in patients with type 2 diabetes (DM2). METHODS: A prospective study was performed in 20 patients with DM2, mean age 51.82 ± 8.05 years, previously treated with dietary int...

Descripción completa

Detalles Bibliográficos
Autores principales: Tostes, Glauce Cordeiro Ulhôa, Cunha, Maria Rosário, Fukui, Rosa Tsumeshiro, Correia, Márcia Regina Silva, Rocha, Dalva Marreiro, dos Santos, Rosa Ferreira, da Silva, Maria Elizabeth Rossi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4700605/
https://www.ncbi.nlm.nih.gov/pubmed/26734075
http://dx.doi.org/10.1186/s13098-015-0120-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4700605/
https://www.ncbi.nlm.nih.gov/pubmed/26734075
http://dx.doi.org/10.1186/s13098-015-0120-6

Ejemplares similares